Bayer Healthcare

In February 2013, a federal court dismissed a class-action lawsuit filed against Bayer for allegedly deceiving consumers with false advertising for Citrical CS, a calcium supplement, that claimed that a single dose of the supplement was equivalent to competing supplements, which require two doses. The basis of the complaint was a report published by the National Advertising Division of the BBB stating that the sole study Bayer had offered to support its labeling claims was unreliable.  The court dismissing the case decided that plaintiffs’ allegations weren’t strong enough to make out a legal claim. (John Gaul v. Bayer Healthcare LLC, Case No. 2:12-cv-05110, D. NJ).

 

Print Friendly, PDF & Email

Tags:



Leave a Reply

Back to Top ↑
  • Search Class-Action Tracker



  • Recent Class Actions

  • The Class-Action Tracker is intended to notify consumers about false advertising class-action lawsuits filed around the country, but does not necessarily reflect TINA.org’s opinion with respect to the lawsuits or disposition of the cases

  • Sign Up for E-mail Updates